Brind.

Tilray Brands, Inc.'s stock change lagged the S&P 500 gain on August 28, 2025, while the company holds a Zacks Rank of #3.

3 reports, 1 independent Updated Aug 28
Gone quiet
Reports
3
Developments
2
Repetition
33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Tilray Brands, Inc.'s stock change lagged the S&P 500 gain on August 28, 2025, while the company holds a Zacks Rank of #3.

Who's involved

What this event is mainly about
Incepta Pharmaceuticals

How it developed

Newest first. Tap a step to see who reported it.
  1. Tilray Brands, Inc. stock lagged S&P 500 gain, despite having a Zacks Rank of #3.1 source
  2. Tilray stock outperformed S&P 500 on July 18, 2025.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksTilray Brands, Inc. (TLRY) Stock Falls Amid Market Uptick: What Investors Need to Know In the latest close session, Tilray Brands, Inc. (TLRY) was down 5.52% at $1.37. This change lagged the S&P 500'
  • ZacksTilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors Tilray Brands, Inc. (TLRY) closed the most recent trading day at $1.03, moving -12.71% from the previous trading s
  • ZacksTilray Brands, Inc. (TLRY) Beats Stock Market Upswing: What Investors Need to Know In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $0.61, marking a +1.21% move from the previous d